A DOUBLE‐BLIND, RANDOMIZED PHASE 3 STUDY TO COMPARE EFFICACY AND SAFETY OF CT‐P10 TO RITUXIMAB IN COMBINATION WITH CVP IN PATIENTS WITH ADVANCED‐STAGE FOLLICULAR LYMPHOMA. (June 2017) - Buske, C.